"Xolair: FDA-Approved Treatment for Severe Food Allergies"
TL;DR Summary
The FDA has approved the antibody drug omalizumab (Xolair) as an injection to reduce allergic reactions to food in people aged 1 and up. In a trial, participants who received omalizumab were more likely to tolerate allergy-inducing foods compared to those who received a placebo. The drug works by binding to immunoglobulin E (IgE) antibodies involved in allergic responses. While it won't eliminate food allergies, it can reduce the health impact of accidental exposure. Side effects include injection site reactions, fever, joint pain, rash, and the possibility of other infections and malignancies.
- New FDA-approved drug makes severe food allergies less life-threatening Ars Technica
- FDA approves medication used to treat asthma for use in people with multiple food allergies CNN
- FDA: People with severe food allergies can get treatment with Xolair USA TODAY
- FDA Approves First Medication For Treating Allergic Reactions To Multiple Foods Forbes
- FDA expands use of asthma drug Xolair to treat severe food allergies The Associated Press
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
88%
759 → 92 words
Want the full story? Read the original article
Read on Ars Technica